vs
Side-by-side financial comparison of ImmunityBio, Inc. (IBRX) and Ponce Financial Group, Inc. (PDLB). Click either name above to swap in a different company.
ImmunityBio, Inc. is the larger business by last-quarter revenue ($38.3M vs $31.4M, roughly 1.2× Ponce Financial Group, Inc.). Ponce Financial Group, Inc. runs the higher net margin — 36.3% vs -161.8%, a 198.1% gap on every dollar of revenue. On growth, ImmunityBio, Inc. posted the faster year-over-year revenue change (407.0% vs 37.6%). Ponce Financial Group, Inc. produced more free cash flow last quarter ($54.6M vs $-71.3M).
ImmunityBio, Inc. is a clinical-stage biotechnology company focused on developing next-generation immunotherapies and vaccine candidates targeting multiple cancer types and infectious diseases. It operates mainly in the U.S. market, with core R&D segments including cell therapy, antibody therapeutics, and targeted vaccine platforms designed to enhance patient treatment outcomes.
Ponce Financial Group, Inc. is a U.S.-based financial holding company operating Ponce Bank as its core subsidiary. It serves multicultural, immigrant and low-to-moderate income communities in the New York metro area, offering retail and commercial banking products including deposits, mortgages, small business financing and personal credit.
IBRX vs PDLB — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $38.3M | $31.4M |
| Net Profit | $-61.9M | $10.1M |
| Gross Margin | 99.0% | — |
| Operating Margin | -169.0% | 43.6% |
| Net Margin | -161.8% | 36.3% |
| Revenue YoY | 407.0% | 37.6% |
| Net Profit YoY | -4.7% | 245.6% |
| EPS (diluted) | $-0.06 | $0.43 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $38.3M | $31.4M | ||
| Q3 25 | $32.1M | $26.7M | ||
| Q2 25 | $26.4M | $26.5M | ||
| Q1 25 | $16.5M | $24.6M | ||
| Q4 24 | $7.6M | $22.8M | ||
| Q3 24 | $6.1M | $20.2M | ||
| Q2 24 | — | $20.2M | ||
| Q1 24 | — | $20.5M |
| Q4 25 | $-61.9M | $10.1M | ||
| Q3 25 | $-67.3M | $6.5M | ||
| Q2 25 | $-92.6M | $6.1M | ||
| Q1 25 | $-129.6M | $6.0M | ||
| Q4 24 | $-59.2M | $2.9M | ||
| Q3 24 | $-85.7M | $2.4M | ||
| Q2 24 | — | $3.2M | ||
| Q1 24 | — | $2.4M |
| Q4 25 | 99.0% | — | ||
| Q3 25 | 99.4% | — | ||
| Q2 25 | 99.5% | — | ||
| Q1 25 | 99.6% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -169.0% | 43.6% | ||
| Q3 25 | -173.5% | 32.8% | ||
| Q2 25 | -269.8% | 30.2% | ||
| Q1 25 | -390.1% | 32.5% | ||
| Q4 24 | -919.0% | 19.6% | ||
| Q3 24 | -1314.3% | 15.2% | ||
| Q2 24 | — | 21.8% | ||
| Q1 24 | — | 18.3% |
| Q4 25 | -161.8% | 36.3% | ||
| Q3 25 | -209.8% | 24.3% | ||
| Q2 25 | -350.3% | 23.0% | ||
| Q1 25 | -784.9% | 24.2% | ||
| Q4 24 | -783.4% | 14.1% | ||
| Q3 24 | -1404.0% | 12.1% | ||
| Q2 24 | — | 15.8% | ||
| Q1 24 | — | 11.8% |
| Q4 25 | $-0.06 | $0.43 | ||
| Q3 25 | $-0.07 | $0.27 | ||
| Q2 25 | $-0.10 | $0.25 | ||
| Q1 25 | $-0.15 | $0.25 | ||
| Q4 24 | $-0.08 | $0.11 | ||
| Q3 24 | $-0.14 | $0.10 | ||
| Q2 24 | — | $0.14 | ||
| Q1 24 | — | $0.11 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $242.8M | $126.2M |
| Total DebtLower is stronger | — | $596.1M |
| Stockholders' EquityBook value | $-500.5M | $541.5M |
| Total Assets | $501.9M | $3.2B |
| Debt / EquityLower = less leverage | — | 1.10× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $242.8M | $126.2M | ||
| Q3 25 | $257.8M | $146.6M | ||
| Q2 25 | $153.7M | $126.6M | ||
| Q1 25 | $61.6M | $129.9M | ||
| Q4 24 | $149.8M | $139.8M | ||
| Q3 24 | $130.4M | $155.8M | ||
| Q2 24 | — | $103.2M | ||
| Q1 24 | — | $134.7M |
| Q4 25 | — | $596.1M | ||
| Q3 25 | — | $521.1M | ||
| Q2 25 | — | $536.1M | ||
| Q1 25 | — | $521.1M | ||
| Q4 24 | — | $596.1M | ||
| Q3 24 | — | $580.4M | ||
| Q2 24 | — | $680.4M | ||
| Q1 24 | — | $680.4M |
| Q4 25 | $-500.5M | $541.5M | ||
| Q3 25 | $-524.3M | $529.8M | ||
| Q2 25 | $-570.7M | $521.1M | ||
| Q1 25 | $-591.4M | $513.9M | ||
| Q4 24 | $-489.1M | $505.5M | ||
| Q3 24 | $-745.1M | $504.6M | ||
| Q2 24 | — | $497.7M | ||
| Q1 24 | — | $493.7M |
| Q4 25 | $501.9M | $3.2B | ||
| Q3 25 | $519.0M | $3.2B | ||
| Q2 25 | $402.1M | $3.2B | ||
| Q1 25 | $303.8M | $3.1B | ||
| Q4 24 | $382.9M | $3.0B | ||
| Q3 24 | $364.6M | $3.0B | ||
| Q2 24 | — | $2.8B | ||
| Q1 24 | — | $2.8B |
| Q4 25 | — | 1.10× | ||
| Q3 25 | — | 0.98× | ||
| Q2 25 | — | 1.03× | ||
| Q1 25 | — | 1.01× | ||
| Q4 24 | — | 1.18× | ||
| Q3 24 | — | 1.15× | ||
| Q2 24 | — | 1.37× | ||
| Q1 24 | — | 1.38× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-70.4M | $55.6M |
| Free Cash FlowOCF − Capex | $-71.3M | $54.6M |
| FCF MarginFCF / Revenue | -186.2% | 173.9% |
| Capex IntensityCapex / Revenue | 2.4% | 3.1% |
| Cash ConversionOCF / Net Profit | — | 5.48× |
| TTM Free Cash FlowTrailing 4 quarters | $-308.8M | $74.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-70.4M | $55.6M | ||
| Q3 25 | $-68.9M | $1.4M | ||
| Q2 25 | $-79.7M | $6.2M | ||
| Q1 25 | $-85.9M | $13.1M | ||
| Q4 24 | $-85.1M | $7.2M | ||
| Q3 24 | $-98.8M | $-14.6M | ||
| Q2 24 | — | $-2.6M | ||
| Q1 24 | — | $1.5M |
| Q4 25 | $-71.3M | $54.6M | ||
| Q3 25 | $-69.6M | $786.0K | ||
| Q2 25 | $-80.8M | $5.9M | ||
| Q1 25 | $-87.0M | $12.9M | ||
| Q4 24 | $-87.3M | $4.5M | ||
| Q3 24 | $-101.6M | $-15.0M | ||
| Q2 24 | — | $-2.6M | ||
| Q1 24 | — | $-315.0K |
| Q4 25 | -186.2% | 173.9% | ||
| Q3 25 | -217.2% | 2.9% | ||
| Q2 25 | -305.9% | 22.4% | ||
| Q1 25 | -526.9% | 52.6% | ||
| Q4 24 | -1155.4% | 19.7% | ||
| Q3 24 | -1663.2% | -74.1% | ||
| Q2 24 | — | -13.0% | ||
| Q1 24 | — | -1.5% |
| Q4 25 | 2.4% | 3.1% | ||
| Q3 25 | 2.3% | 2.3% | ||
| Q2 25 | 4.1% | 1.0% | ||
| Q1 25 | 6.8% | 0.6% | ||
| Q4 24 | 28.0% | 11.9% | ||
| Q3 24 | 45.7% | 2.0% | ||
| Q2 24 | — | 0.3% | ||
| Q1 24 | — | 8.7% |
| Q4 25 | — | 5.48× | ||
| Q3 25 | — | 0.21× | ||
| Q2 25 | — | 1.01× | ||
| Q1 25 | — | 2.20× | ||
| Q4 24 | — | 2.46× | ||
| Q3 24 | — | -5.99× | ||
| Q2 24 | — | -0.80× | ||
| Q1 24 | — | 0.61× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
